about
Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.Critical role of toxicologic pathology in a short-term screen for carcinogenicityOptimizing mouse models for precision cancer prevention.Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care.Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.Evaluation of the carcinogenicity of inorganic arsenic.Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.O-phenylphenol and its sodium and potassium salts: a toxicological assessment.Comparative pathology of proliferative lesions of the urinary bladder.Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin.Modelling bladder cancer in mice: opportunities and challenges.Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse modelInfluence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program.Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urotheliumTranscriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders.Id Proteins Contribute to Tumor Development and Metastatic Colonization in a Model of Bladder Carcinogenesis.p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.Urological implications of cyclophosphamide and ifosfamide.The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney diseaseExamining the safety of PPAR agonists - current trends and future prospects.Diuron-induced rat urinary bladder carcinogenesis: mode of action and human relevance evaluations using the International Programme on Chemical Safety framework.Successful integration of nonclinical and clinical findings in interpreting the clinical relevance of rodent neoplasia with a new chemical entity.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C.No Promoting Effect of Ethyl Tertiary-butyl Ether (ETBE) on Rat Urinary Bladder Carcinogenesis Initiated with N-Butyl-N-(4-hydroxybutyl)nitrosamine.Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.Effect of sulfosulfuron on the urine and urothelium of male rats.Diuron-induced rat bladder epithelial cytotoxicity.Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.Proliferative and nonproliferative lesions of the rat and mouse urinary system.Planimetric and Biomechanical Study of Local Effect of Pulegone on Full Thickness Wound Healing in Rat.The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.Mode of action of pulegone on the urinary bladder of F344 rats.Raf inhibition causes extensive multiple tissue hyperplasia and urinary bladder neoplasia in the rat.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
P2860
Q24530138-335472E0-CA9B-405E-B964-095892568097Q27690887-7C22D19D-97F6-419D-966A-CAE994A6035EQ28075960-E668E6F0-3487-44FD-AD68-78A4658AE685Q33919192-B237730A-940F-448B-BABF-73EB2C2078FBQ34011001-3937A3AD-8257-4FB5-933A-21F59269A0D3Q34161803-98BC3814-44F5-47AF-B051-3C8AE65CD5E4Q34371580-42469CB2-5B7B-460A-84A0-6C1EF44D72EBQ34567906-0100FA4A-6B23-45F9-B115-6FB141204F7EQ35028250-7B3DD50F-8C0B-40A4-8956-2F39DC42923DQ35038992-7E966C58-13B0-48E3-8B40-A7D8952FFFF8Q35128660-7033796C-4B91-450B-921F-AF90C60CCE87Q35285703-2DF5ABF3-9E14-409D-A2A4-2A61A6CC9595Q35829505-B0D6C3FF-DCE9-4F93-821A-822055DCB1C7Q36086179-21E961FE-088C-4991-8277-E30899A2998EQ36210174-9B3492C3-2571-4097-B5FA-209E77D0BF89Q36475458-9DDF5798-4C0C-4FD3-B59F-3AF291DF11B4Q36672637-254C0929-A415-40BC-8BF0-D0AD7C55351CQ36800005-B6EA0DA1-AEBE-4D0A-B22C-934A5E39004BQ37053962-8FFFEBE1-354F-43EB-8EE2-4F69F49EF2C4Q37061038-51FFABB1-2874-4E8D-B430-A26D8374EA59Q37264407-98411412-A5AF-4489-99F8-57345E11E99CQ37464712-920D67D3-33F7-4AD6-8451-F9074FF64456Q38058381-094D8A26-BFFD-481B-8EBC-6DE9C9FC7B9FQ38186798-040BDA43-63B0-42E3-8315-AA97C1FA2204Q38562860-E28E989C-E5D9-46A1-B16E-21FDF19EBEFBQ38651175-EC500DD2-4D69-45C8-A578-729D9EC114D6Q41339763-E14242DF-AAC3-4DE9-88D9-0FB663D2544EQ41678957-1C131F39-3DFB-44D3-9F29-884A4BD158FEQ41945535-EB72396E-66A4-463E-9480-826D71F7A991Q42481705-DC7CCC92-8723-42E8-9A19-11959EBD7622Q42506993-4466582D-2348-42FA-849F-28AA744179DAQ42716241-C6D214BA-39B4-48A0-866B-DC6C818C6A3CQ46363284-C9790F89-1872-4E13-B954-21A6E775E852Q48636042-8B1FA403-46FD-48E4-B777-6344DAE82823Q49239357-3203BD1E-9B03-4221-A70B-276F3224B355Q50182629-9380567B-FFD8-46C0-9F79-0DB8F4660F00Q51346761-04CBFFFB-33E5-4EE9-9387-48FC6015B002Q51449752-4C5193EC-716D-42D4-9D71-CFC29D8DA931Q53338744-244E9A87-8B03-4A6D-80F8-B782ED11F84C
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Urinary bladder carcinogenesis.
@en
type
label
Urinary bladder carcinogenesis.
@en
prefLabel
Urinary bladder carcinogenesis.
@en
P2860
P1476
Urinary bladder carcinogenesis.
@en
P2093
P2860
P304
P356
10.1177/019262339802600114
P407
P577
1998-01-01T00:00:00Z